Daiken Biomedical Co., Ltd. (TPE:7780)
13.95
-0.55 (-3.79%)
At close: Nov 19, 2026
Daiken Biomedical Market Cap
Daiken Biomedical has a market cap or net worth of 11.24 billion as of November 19, 2026. It is the 16,637th most valuable company in the world and the 575th biggest in Taiwan. Its market cap has decreased by 22.28% in one year.
Market Cap
11.24B
Enterprise Value
6.96B
Revenue
2.34B
Global Rank
Country Rank
#575 Taiwan
PE Ratio
24.10
ChartMarket Cap Chart
Since October 28, 2024, Daiken Biomedical's market cap has increased from 10.68B to 11.24B, an increase of 5.22%. That is a compound annual growth rate of 2.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 11.24B | -22.71% |
| Dec 31, 2025 | 14.54B | 33.88% |
| Dec 31, 2024 | 10.86B | 1.69% |
| Oct 28, 2024 | 10.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lian Hwa Foods | 23.18B |
| Standard Foods | 22.71B |
| Grape King Bio | 11.39B |
| Ve Wong | 10.40B |
| Tehmag Foods | 9.15B |
| Microbio | 7.53B |
| Namchow Holdings | 7.15B |
| Chung Hwa Food Industrial | 6.27B |